Yasemin DADAS | Cancer Cell Biology | Innovative Research Award

Published on by Oncology

Innovative Research Award

Yasemin Dadas 
Nigde Omer Halisdemir University, Turkey
Yasemin Dadas
Affiliation Department of Obstetrics and Gynecology, Faculty of Medicine, Nigde Omer Halisdemir University
Country Turkey
Scopus ID 60163710500
Documents 2
Citations 3
h-index 1
Subject Area Cancer Cell Biology
Event International Research Awards on Oncology and Cancer Research

Yasemin Dadas is a researcher and academic physician affiliated with the Department of Obstetrics and Gynecology, Faculty of Medicine, Nigde Omer Halisdemir University, Turkey. Publicly available academic records associate her research with obstetrics and gynecology and with oncology-related questions, including fertility preservation in women with pelvic gynecologic malignancies. Her institutional affiliation is also listed in the academic staff records of Nigde Omer Halisdemir University. [1] [2]

Abstract

Yasemin Dadas is affiliated with the Department of Obstetrics and Gynecology at Nigde Omer Halisdemir University in Turkey. Her documented scholarly work includes research involving reproductive medicine and gynecologic oncology. A 2026 systematic review co-authored by Dadas examines fertility preservation strategies for women with pelvic gynecologic malignancies and considers the integration of oncologic surgery, chemotherapy, radiotherapy, and multidisciplinary care. [2] Her publication record also includes research concerning progesterone protocols used in frozen-thawed embryo transfer preparation. [3]

Keywords

Yasemin Dadas; Cancer Cell Biology; gynecologic oncology; pelvic gynecologic malignancies; fertility preservation; reproductive medicine; obstetrics and gynecology; oncology research; multimodal cancer care; Nigde Omer Halisdemir University.

Introduction

Research at the intersection of gynecology, reproductive medicine, and oncology addresses clinical questions that affect both cancer treatment and reproductive potential. In pelvic gynecologic malignancies, fertility preservation can form part of multidisciplinary treatment planning, particularly when surgery and subsequent anticancer therapies may affect reproductive function. Dadas’ published work contributes to this clinical research area through a systematic review focused on fertility preservation strategies in women undergoing multimodal oncologic treatment. [2]

Research Profile

The available academic record places Yasemin Dadas within obstetrics and gynecology, with published research spanning reproductive medicine and subjects relevant to gynecologic oncology. Her institutional profile identifies her as a faculty member in the Department of Obstetrics and Gynecology at Nigde Omer Halisdemir University. [1]

Research Contributions

A principal documented contribution is the systematic examination of fertility preservation strategies for women with pelvic gynecologic malignancies. The review evaluates approaches used around pelvic oncologic surgery and subsequent treatment and emphasizes the need to consider reproductive outcomes alongside oncologic management. [2]

Publications

The two publications listed above are independently identifiable through scholarly bibliographic sources and correspond with the supplied Scopus document count. The 2026 systematic review is indexed in PubMed and PubMed Central, while the 2025 Biomedicines article is also indexed in PubMed. [2] [3]

Research Impact

The supplied bibliometric profile reports 2 documents, 3 citations, and an h-index of 1 for Scopus Author ID 60163710500. These indicators describe the citation record associated with the supplied profile and should be interpreted in relation to publication age, field-specific citation patterns, and the size of the documented publication portfolio.

Award Suitability

For an academic recognition profile under the Innovative Research Award, the documented record provides identifiable evidence of research activity in obstetrics and gynecology, reproductive medicine, and gynecologic oncology. In particular, the systematic review on fertility preservation in pelvic gynecologic malignancies directly addresses a cancer-care research question and incorporates multiple dimensions of oncologic treatment. [2]

Conclusion

Yasemin Dadas has a documented academic profile at Nigde Omer Halisdemir University in Turkey, with research spanning obstetrics and gynecology, reproductive medicine, and gynecologic oncology. Her published work includes a systematic review addressing fertility preservation in women with pelvic gynecologic malignancies and a study of progesterone protocols for frozen-thawed embryo transfer. [2] [3]

1.Scopus Author Profile — Yasemin Dadas, Author ID 60163710500

2. Comparison of Different Progesterone Protocols for Luteal Support

3.  International Research Awards on Oncology and Cancer Research — Award Website

References

1.Niğde Ömer Halisdemir Üniversitesi. (n.d.). Faculty of Medicine — Academic Staff / Department of Surgical Medical Sciences. The institutional listing        identifies Yasemin Dadaş within the Department of Obstetrics and Gynecology.
    https://www.ohu.edu.tr/facultyofmedicine/academic-staff2

2.Dadas, Y., Oner, G., Karaman, E., Ayan, D., Doganay, H. N., Bayram, E., Tunca Sanlier, N., & Kulular, B. (2026). Fertility Preservation Strategies in          Women with Pelvic Gynecologic Malignancies Undergoing Multimodal Oncologic Treatment: A Systematic Review. Cancers, 18(7), 1142.
    https://doi.org/10.3390/cancers18071142

3.Oner, G., Karaman, E., Kulular, B., Dadas, Y., & Doganay, H. N. (2025). Comparison of Different Progesterone Protocols for Luteal Support in Frozen-      Thawed Embryo Transfer Preparation. Biomedicines, 13(10), 2487.
     https://dergipark.org.tr/tr/pub/@yasemin-dadas

4.Elsevier. (n.d.). Scopus Author Details: Yasemin Dadas, Author ID 60163710500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60163710500

5.International Research Awards on Oncology and Cancer Research. (n.d.). Official Award Website.
    https://oncology.pencis.com/

 

Kimberly Rieger | Cancer Cell Biology | Innovative Research Award

Published on by Oncology

Innovative Research Award

Kimberly Rieger
Lahey Clinic, United States

              Kimberly Rieger
Affiliation Lahey Clinic
Country United States
Scopus ID 6602699362
Documents 87
Citations 15,323
h-index 33
Subject Area Cancer Cell Biology
Event International Research Awards on Oncology and Cancer Research
ORCID 0000-0002-8425

Kimberly Rieger is a cancer researcher associated with Lahey Clinic and the Cell and Molecular Biology research environment at Lahey Hospital & Medical Center. Her published work spans molecular oncology, cancer biology, microRNA regulation, tumor progression, biomarkers, and mechanisms associated with treatment response. [1]

Abstract

The Innovative Research Award profile recognizes Kimberly Rieger-Christ in the context of cancer cell biology and translational oncology research. Her research record includes studies examining molecular regulators of tumor behavior, microRNA-associated pathways, cancer biomarkers, metastatic phenotypes, and mechanisms influencing treatment response. [3] Such research contributes to understanding how molecular alterations can influence cancer progression and clinical outcomes.

Keywords

Cancer Cell Biology; Cancer Research; Molecular Oncology; MicroRNA; Bladder Cancer; Renal Cell Carcinoma; Lung Cancer; Biomarkers; Tumor Progression; Metastasis; Treatment Resistance; Translational Research; Molecular Diagnostics; Oncology.

Introduction

Cancer cell biology investigates the molecular and cellular processes that regulate malignant transformation, proliferation, invasion, metastasis, and response to therapy. Within this field, microRNAs and other regulatory molecules are important because they can influence multiple genes and signaling pathways simultaneously. Rieger-Christ’s published research has addressed these mechanisms across several cancer contexts, particularly urologic malignancies. [5]

Research Profile

The available research record places Rieger-Christ within a multidisciplinary cancer research environment involving molecular biology, genetics, gene expression, cell signaling, and cancer genomics. Her work has included experimental and translational studies addressing bladder cancer, renal cell carcinoma, prostate cancer, and lung cancer.Institutional sources describe research interests that include the molecular basis of genitourinary cancers and the development of improved approaches for diagnosis, prevention, and treatment. [2]

Research Contributions

A recurring contribution in the research record is investigation of microRNA biology in cancer. Published work has examined microRNA profiles associated with gemcitabine resistance in bladder carcinoma cell lines and microRNA signatures associated with invasive disease. [3] These studies address mechanisms that may help explain differences in tumor behavior and therapeutic response.

Publications

Selected publications associated with Kimberly Rieger-Christ demonstrate a sustained focus on molecular oncology. Her work includes studies of microRNA-mediated regulation, cancer invasion, treatment resistance, and molecular characteristics of tumor progression. The Lahey research publication archive records multiple contributions across these areas and provides DOI information for several publications. [3]

  • Kozinn et al. (2013), “MicroRNA Profile to Predict Gemcitabine Resistance in Bladder Carcinoma Cell Lines.”
  • Das et al. (2023), “The Roles of MiRNAs in Predicting Bladder Cancer Recurrence and Resistance to Treatment.”
  • Kalantzakos et al. (2023), “MicroRNA-155-5p Targets JADE-1, Promoting Proliferation, Migration, and Invasion in Clear Cell Renal Cell Carcinoma Cells.”

Research Impact

Research impact in cancer biology can be assessed through publication continuity, citation activity, methodological relevance, and contribution to clinically meaningful scientific questions. The supplied profile records 87 documents, 15,323 citations, and an h-index of 33. These figures are presented as the profile information supplied for this recognition page and may change as bibliographic databases are updated.The scientific relevance of the work is also reflected in its connection to cancer recurrence, treatment resistance, invasion, metastasis, and biomarker development. . [2]

Award Suitability

The Innovative Research Award is presented here as a recognition framework aligned with research activity in oncology and cancer cell biology. Rieger-Christ’s documented work in molecular cancer mechanisms, microRNA regulation, tumor progression, and translational research provides subject-matter relevance to an international research awards program focused on oncology and cancer research.Award suitability should ultimately be determined through the applicable nomination criteria, supporting evidence, peer or committee assessment, and verification of bibliographic information[2].

Conclusion

Kimberly Rieger-Christ’s research profile reflects sustained engagement with cancer cell biology and molecular oncology, with particular emphasis on microRNA regulation, tumor progression, metastatic phenotypes, treatment resistance, and biomarkers. Her publication record includes research addressing several clinically significant cancer types and molecular mechanisms.Within the context of the International Research Awards on Oncology and Cancer Research, these areas provide a reasonable scholarly basis for consideration under an Innovative Research Award category. The profile should be interpreted alongside current bibliographic records, institutional information, and the formal award evaluation process [3].

References

  1. ResearchGate. (n.d.). Kimberly Rieger-Christ research profile. ResearchGate.
    https://www.researchgate.net/profile/Kimberly-Rieger-Christ
  2. Lahey Hospital & Medical Center. (n.d.). Research: Ian C. Summerhayes Cell and Molecular Biology Laboratory.
    https://research.lahey.org/icsmb/research
  3. Lahey Hospital & Medical Center. (n.d.). Publications of the Ian C. Summerhayes Cell and Molecular Biology Laboratory.
    https://research.lahey.org/icsmb/publications?page=1
  4. Rieger-Christ, K. M., et al. (2015). A non-invasive miRNA based assay to detect bladder cancer in cell-free urine. Asian Journal of Translational Medicine Research.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4697726/
  5. Elsevier. (n.d.). Scopus author details: Kimberly Rieger-Christ, Author ID 6602699362. Scopus.
    https://www.scopus.com/pages/authors/6602699362

Nour Abu Jayab | Cancer Cell Biology | Innovative Research Award

Published on by Oncology

Innovative Research Award

Nour Abu Jayab
University of Sharjah

                 Nour Abu Jayab
Affiliation University of Sharjah
Country United Arab Emirates
Scopus ID 58147288600
Documents 5
Citations 110
h-index 4
Subject Area Cancer Cell Biology
Event International Research Awards on Oncology and Cancer Research

Nour Abu Jayab is a researcher affiliated with the University of Sharjah whose scholarly activities contribute to the advancement of cancer cell biology and related biomedical investigations. Her publication record, citation performance, and research visibility demonstrate active engagement in contemporary oncology research. The Innovative Research Award recognizes scientific contributions that support the understanding of cancer mechanisms, translational biology, and evidence-based innovation within oncology and cancer research disciplines.[1][2]

Abstract

Nour Abu Jayab has established a developing research profile within cancer cell biology through contributions focused on understanding cellular mechanisms associated with cancer progression and therapeutic response. Her scholarly output demonstrates engagement with contemporary oncology challenges, including translational research and biomedical innovation. With a documented publication record and measurable citation impact, her work has contributed to scientific discussions within oncology-related disciplines. The combination of research productivity, interdisciplinary collaboration, and influence reflected through citation metrics supports recognition for innovative scientific achievement within the framework of the International Research Awards on Oncology and Cancer Research.[1][2]

Keywords

Cancer Cell Biology, Oncology Research, Translational Medicine, Cancer Mechanisms, Biomedical Research, Cellular Signaling, Tumor Biology, Scientific Innovation, Cancer Therapeutics, Research Impact

Introduction

Cancer research continues to rely on innovative investigations that improve understanding of cellular behavior, disease progression, and treatment response. Nour Abu Jayab contributes to this field through scholarly activities focused on cancer cell biology, supporting scientific knowledge relevant to modern oncology and translational biomedical research.[1]

Research Profile

Affiliated with the University of Sharjah, Nour Abu Jayab has developed a research portfolio within oncology-related disciplines. Her Scopus-indexed publications, citation performance, and measurable h-index indicate growing academic visibility and engagement with topics connected to cancer biology and biomedical sciences.[1][2]

Research Contributions

Her research contributions support understanding of biological processes relevant to cancer development and treatment. Through peer-reviewed publications, she has participated in advancing scientific evidence, encouraging interdisciplinary collaboration, and contributing to the broader knowledge base that informs future oncology investigations.[1][3]

Publications

The researcher maintains a Scopus-indexed publication record consisting of five documented scholarly works. These publications collectively address themes associated with cancer biology and biomedical research, contributing to scientific communication and supporting evidence-based advancement within oncology-related fields.[1]

Research Impact

With more than one hundred citations and an established h-index, Nour Abu Jayab’s research demonstrates measurable scholarly influence. Citation activity indicates that her publications have been referenced by other researchers, reflecting relevance and contribution to ongoing discussions within cancer and biomedical sciences.[1][2]

Award Suitability

The Innovative Research Award recognizes originality, scientific contribution, and research influence. Based on documented publication metrics, citation performance, and engagement in cancer cell biology, Nour Abu Jayab demonstrates characteristics aligned with award criteria emphasizing innovation, academic excellence, and contributions to oncology research.[1]

Conclusion

Nour Abu Jayab’s scholarly profile reflects active participation in cancer cell biology research. Her publication record, citation impact, and contribution to oncology-related knowledge support recognition within international research award programs that value innovation, scientific rigor, and meaningful advancement of biomedical science.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Nour Abu Jayab, Author ID 58147288600. Scopus.https://www.scopus.com/authid/detail.uri?authorId=58147288600
  2. Abu Jayab, N., Abed, A., Talaat, I. M., & Hamoudi, R. (Year). The molecular mechanism of NF-κB dysregulation across different subtypes of renal cell carcinoma.https://pmc.ncbi.nlm.nih.gov/articles/PMC12147641/
  3. ResearchGate. (n.d.). Nour Abu Jayab Research Profile and Publications.https://www.researchgate.net/profile/Nour-Abu-Jayab